美国 · SEC FORM 4
Nano-X Imaging Ltd.
NNOX · Nasdaq · CIK 0001795251 · Healthcare · Medical Devices
内部人信号
3 位买方 · 9 条买入交易行 · $179.4K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Chief Executive Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 60.0
- 59.9
- 59.8
- 59.6
- 59.4
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -26.3%
- 3M
- -48.8%
- 6M
- -76.3%
- 12M
- -87.6%
波动率与流动性
- 波动率
- 88.3%
- Beta
- —
- 平均每日成交额
- USD 619,052
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -576.1%
- ROE
- -53.7%
- 细分行业
- Medical Devices
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 6,303,398
- 上期报告
- 6,760,532
- 日均成交量
- 896,007
- 回补天数
- 7.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Meltzer Erez | 买入 (P) | Ordinary Shares | 10,000 | USD 0.69 | USD 6,900 | SEC 申报 ↗ |
| 2026-09-14 | Suesskind Dan S | 买入 (P) | Ordinary Shares | 60,000 | USD 0.76 | USD 45,300 | SEC 申报 ↗ |
| 2026-09-10 | Meltzer Erez | 买入 (P) | Ordinary Shares | 10,000 | USD 0.78 | USD 7,800 | SEC 申报 ↗ |
| 2026-08-10 | Meltzer Erez | 买入 (P) | Ordinary Shares | 9,443 | USD 1.03 | USD 9,726 | SEC 申报 ↗ |
| 2026-07-28 | Kainan Noga | 买入 (P) | Ordinary Shares | 33,000 | USD 0.90 | USD 29,700 | SEC 申报 ↗ |
| 2026-07-27 | Suesskind Dan S | 买入 (P) | Ordinary Shares | 50,000 | USD 0.93 | USD 46,500 | SEC 申报 ↗ |
| 2026-07-27 | Meltzer Erez | 买入 (P) | Ordinary Shares | 36,000 | USD 0.93 | USD 33,480 | SEC 申报 ↗ |
| 2025-09-05 | Daniel Ran | 买入 (P) | Ordinary shares | 1,000 | USD 3.65 | USD 3,650 | SEC 申报 ↗ |
Form 4 申报证据
20 transaction lines in the latest 365-day window; 21 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | saban sharon | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-14 | Yahav Attias Gali | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-14 | Nathansohn Guy | 奖励／授予 (A) | Ordinary Shares | 50,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (17 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | saban sharon | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-14 | Yahav Attias Gali | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-14 | Nathansohn Guy | 奖励／授予 (A) | Ordinary Shares | 50,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-13 | Gofman Feler Marina | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-11 | Dara James | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-11 | Aharon Cohen Tamar | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-10 | Koren Ofir | 奖励／授予 (A) | Ordinary Shares | 28,283 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-15 | Meltzer Erez | 买入 (P) | Ordinary Shares | 10,000 | USD 0.69 | USD 6,900 | SEC 申报 ↗ |
| 2026-09-14 | Suesskind Dan S | 买入 (P) | Ordinary Shares | 60,000 | USD 0.76 | USD 45,300 | SEC 申报 ↗ |
| 2026-09-10 | Meltzer Erez | 买入 (P) | Ordinary Shares | 10,000 | USD 0.78 | USD 7,800 | SEC 申报 ↗ |
| 2026-08-10 | Meltzer Erez | 买入 (P) | Ordinary Shares | 9,443 | USD 1.03 | USD 9,726 | SEC 申报 ↗ |
| 2026-07-29 | Daniel Ran | D (D) | Ordinary Shares | 1,000 | USD 0.89 | USD 890 | SEC 申报 ↗ |
| 2026-07-28 | Kainan Noga | 买入 (P) | Ordinary Shares | 33,000 | USD 0.90 | USD 29,700 | SEC 申报 ↗ |
| 2026-07-27 | Suesskind Dan S | 买入 (P) | Ordinary Shares | 50,000 | USD 0.93 | USD 46,500 | SEC 申报 ↗ |
| 2026-07-27 | Meltzer Erez | 买入 (P) | Ordinary Shares | 36,000 | USD 0.93 | USD 33,480 | SEC 申报 ↗ |
| 2026-06-10 | Alroy Erez | 卖出 (S) | Ordinary Shares | 678 | USD 1.65 | USD 1,119 | SEC 申报 ↗ |
| 2026-03-18 | Daniel Ran | D (D) | Ordinary shares | 39,474 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NNOX |
| CIK | 0001795251 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 21 transaction lines from 2025-09-05 to 2026-10-14 10 P purchase lines · 2 S sale lines · 9 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.